Cardiac involvement in a patient with B-cell lymphoblastic lymphoma/acute lymphoblastic leukemia and a history of allogeneic hematopoietic stem cell transplantation and CAR T-cell therapy: A case report

被引:1
|
作者
Cao, Yigeng [1 ,2 ]
Liu, Yadan [3 ]
Zhang, Rongli [1 ,2 ]
Zhai, Weihua [1 ,2 ]
Ma, Qiaoling [1 ,2 ]
Wei, Jialin [1 ,2 ]
Yang, Donglin [1 ,2 ]
Pang, Aiming [1 ,2 ]
He, Yi [1 ,2 ]
Chen, Xin [1 ,2 ]
Jiang, Erlie [1 ,2 ]
Feng, Sizhou [1 ,2 ]
Han, Mingzhe [1 ,2 ]
机构
[1] Chinese Acad Med Sci & Peking Union Med Coll, Inst Hematol, Natl Clin Res Ctr Blood Dis, State Key Lab Expt Hematol,Haihe Lab Cell Ecosyst, Tianjin, Peoples R China
[2] Chinese Acad Med Sci & Peking Union Med Coll, Blood Dis Hosp, Tianjin, Peoples R China
[3] Ningbo First Hosp, Ningbo Clin Res Ctr Hematol Malignancies, Hematol Dept, Ningbo, Peoples R China
来源
FRONTIERS IN IMMUNOLOGY | 2023年 / 13卷
关键词
B cell acute lymphoblastic leukemia; B cell lymphoblastic lymphoma; allogeneic hematopoietic stem cell transplantation; chimeric antigen receptor T cells; cardiac involvement; MANAGEMENT; DIAGNOSIS; NEOPLASMS;
D O I
10.3389/fimmu.2022.1052336
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Cardiac involvement in hematological malignancies is uncommon, with only a few cases reported to date, and it often leads to a poor prognosis. Here, we report a case of a 42-year-old woman with a history of allogeneic hematopoietic stem cell transplantation (allo-HSCT) and anti-CD19 chimeric antigen receptor (CAR) T-cell therapy for B-cell lymphoblastic lymphoma/acute lymphoblastic leukemia in whom cardiac mass and myocardial infiltration were detected. Prior to this presentation, massive pericardial effusion had occurred 6 months after CAR T-cell therapy, which was improved via ultrasound-guided pericardiocentesis. We observed elevated cytokine levels and increased copy number of CAR DNA in both pericardial effusion and serum. Upon detecting cardiac mass and myocardial infiltration, the patient was administered tocilizumab (a humanized monoclonal antibody against IL-6 receptor), which controlled the serum cytokine levels, and reduced intensity chemotherapy, including vindesine, cyclophosphamide, and prednisolone. However, the patient finally died of multiple organ failure. To the best of our knowledge, this is the first report on the development of a cardiac mass and occurrence of myocardial infiltration after allo-HSCT and CAR T-cell therapy. This report may provide supporting data for the early diagnosis and immediate treatment of patients with cardiac involvement.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Multiple CAR-T cell therapy for acute B-cell lymphoblastic leukemia after hematopoietic stem cell transplantation: A case report
    Deng, Lei
    Yu, Xiaolin
    Wu, Qian
    Song, Xiaochen
    Li, Wenjun
    Hou, Yixi
    Liu, Yue
    Wang, Jing
    Tian, Jun
    Zuo, Xiaona
    Zhou, Fang
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [2] Extramedullary relapse of acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation treated by CAR T-cell therapy: a case report
    Wang, Dongmei
    Shi, Rui
    Wang, Qinglong
    Li, Jianqiang
    ONCOTARGETS AND THERAPY, 2018, 11 : 6327 - 6332
  • [3] CAR-T cells and allogeneic hematopoietic stem cell transplantation for relapsed/refractory B-cell acute lymphoblastic leukemia
    Liu, Jun
    Zhang, Xi
    Zhong, Jiang F.
    Zhang, Cheng
    IMMUNOTHERAPY, 2017, 9 (13) : 1115 - 1125
  • [4] Center effect on allogeneic hematopoietic stem cell transplantation outcomes for B-cell acute lymphoblastic leukemia
    Kurosawa, Shuhei
    Fukuda, Takahiro
    Ichinohe, Tatsuo
    Hashii, Yoshiko
    Kanda, Junya
    Goto, Hideki
    Kato, Koji
    Yoshimitsu, Makoto
    Ishimaru, Fumihiko
    Sato, Atsushi
    Onizuka, Makoto
    Matsuo, Keitaro
    Ito, Yuri
    Yanagisawa, Atsumi
    Ohbiki, Marie
    Tabuch, Ken
    Atsuta, Yoshiko
    Arai, Yasuyuki
    CYTOTHERAPY, 2024, 26 (10) : 1185 - 1192
  • [5] Allogeneic Hematopoietic Stem Cell Transplantation Following CAR T Therapy in Relapsed/Refractory Acute Lymphoblastic Leukemia
    Rafaeli, Natalie
    Marin, David
    Ledesma, Celina
    Jain, Nitin
    Tewari, Priti
    Khouri, Issa F.
    Olson, Amanda L.
    Alatrash, Gheath
    Short, Nicholas J.
    Jabbour, Elias
    Rezvani, Katy
    Alousi, Amin M.
    Popat, Uday
    Champlin, Richard E.
    Shpall, Elizabeth J.
    Kebriaei, Partow
    BLOOD, 2024, 144 : 2810 - 2811
  • [6] CAR-T Cell Therapy in B-Cell Acute Lymphoblastic Leukemia
    Testa, Ugo
    Sica, Simona
    Pelosi, Elvira
    Castelli, Germana
    Leone, Giuseppe
    MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 2024, 16 (01)
  • [7] ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA AND LYMPHOBLASTIC LYMPHOMA: OUTCOMES AT THE NATIONAL CANCER CENTER HOSPITAL (NCCH) OF JAPAN
    Sakata, Masanori
    Watanabe, Mizuki
    Kim, Sung Won
    Usui, Asako
    Takeda, Wataru
    Tanaka, Takashi
    Ito, Ayumu
    Inamoto, Yoshihiro
    Fukuda, Takahiro
    BONE MARROW TRANSPLANTATION, 2023, 58 (SUPP1) : 159 - 159
  • [8] The future of CAR T-cell therapy for B-cell acute lymphoblastic leukemia in pediatrics and adolescents
    Schultz, Liora
    Mackall, Crystal L.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2023, 23 (07) : 633 - 640
  • [9] Cytomegalovirus pneumonia in a patient with T-lymphoblastic leukemia/lymphoma after allogeneic hematopoietic stem cell transplantation A case report
    Li, Qiuyu
    Wang, Kai
    Guo, Wei
    Lu, Ming
    MEDICINE, 2019, 98 (04)
  • [10] Selection of hematopoietic stem cell transplantation for T-cell lymphoblastic lymphoma
    Li, Zhen
    Zhang, Binglei
    Fan, Xinxin
    Gui, Ruirui
    Yu, Fengkuan
    Wang, Juan
    Zhang, Yanli
    Zhou, Keshu
    Liu, Yanyan
    Li, Yufu
    Ding, Jing
    Song, Yongping
    Zhou, Jian
    FRONTIERS IN ONCOLOGY, 2023, 13